Pharma stocks fall after Trump’s 200% tariff announcement for generic imports
President Trump's tariff plan for imported generic medicines has caused a 2% decrease in the Nifty Pharma Index and a deeper cut for large-cap and mid- and small-cap stocks. His statement about a 100% tariff on generic drug imports in 2028 has raised concerns for Indian pharma companies, but experts believe their economic viability will not be affected.